Published in J Geriatr Cardiol on December 01, 2011
Cardiovascular considerations in antidepressant therapy: an evidence-based review. J Tehran Heart Cent (2013) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Adverse drug reactions: definitions, diagnosis, and management. Lancet (2000) 16.12
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis (2006) 8.23
Depression and 18-month prognosis after myocardial infarction. Circulation (1995) 7.22
Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc (1959) 6.80
Causes of the excess mortality of schizophrenia. Br J Psychiatry (2000) 5.40
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33
Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database. Arch Gen Psychiatry (2007) 4.26
Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry (2001) 4.18
Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry (2001) 4.15
Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA (2003) 4.07
Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry (2010) 3.96
Fatal overdose with citalopram. Lancet (1996) 3.91
Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation (2002) 3.47
The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med (2010) 3.42
Psychological stress and cardiovascular disease. J Am Coll Cardiol (2008) 3.41
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res (2003) 3.36
Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol (2010) 3.23
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res (2005) 2.91
Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation (1996) 2.88
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med (2009) 2.72
Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation. BMJ (2000) 2.65
Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation (1994) 2.50
A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol (2004) 2.50
Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation (1996) 2.27
Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol (1995) 2.17
Adverse effects of antipsychotic medications. Am Fam Physician (2010) 2.12
Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation (1994) 2.10
Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:The Heart and Soul Study. Arch Gen Psychiatry (2010) 1.99
Routine screening for depression in patients with coronary heart disease never mind. J Am Coll Cardiol (2009) 1.99
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J (2000) 1.92
A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand (1991) 1.74
Association of hostility with coronary artery calcification in young adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. JAMA (2000) 1.74
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis. J Psychopharmacol (2009) 1.70
MAO inhibitors: risks, benefits, and lore. Cleve Clin J Med (2010) 1.70
Major depressive disorder in coronary artery disease. Am J Cardiol (1987) 1.69
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des (2004) 1.63
Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol (1998) 1.61
'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors. J Clin Psychiatry (1988) 1.60
Recent evidence linking coronary heart disease and depression. Can J Psychiatry (2006) 1.60
The influence of sex on pharmacokinetics. Clin Pharmacokinet (2003) 1.57
Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry (1993) 1.53
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol (2004) 1.50
Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry (1998) 1.48
Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med (1977) 1.47
Case study: two additional sudden deaths with tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry (1997) 1.44
Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med (2007) 1.42
Sudden death in children treated with a tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry (1991) 1.42
Influence of gender and menopause on gastric emptying and motility. Gastroenterology (1989) 1.38
Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis (2004) 1.32
The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol (1975) 1.28
Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA (1978) 1.27
Gender differences in pharmacological response. Int Rev Neurobiol (2008) 1.26
Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke (2007) 1.24
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol (1998) 1.23
Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry (1981) 1.23
New antipsychotics, compliance, quality of life, and subjective tolerability--are patients better off? Can J Psychiatry (2004) 1.23
Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther (1995) 1.17
Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf (2001) 1.15
Reducing psychosocial stress: a novel mechanism of improving survival from exercise training. Am J Med (2009) 1.15
Side effects of atypical antipsychotics: a brief overview. World Psychiatry (2008) 1.13
Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging (2011) 1.12
The time has come for physicians to take notice: the impact of psychosocial stressors on the heart. Am J Med (2009) 1.11
Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol (2009) 1.10
Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet (1979) 1.09
Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol (2001) 1.08
Prevalence of anxiety in coronary patients with improvement following cardiac rehabilitation and exercise training. Am J Cardiol (2004) 1.05
Depression in patients with coronary artery disease. Depression (1996) 1.05
What does heart disease have to do with anxiety? J Am Coll Cardiol (2010) 1.05
Cardiac side effects of psychiatric drugs. Hum Psychopharmacol (2008) 1.04
A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry (2007) 1.01
Impact of exercise training on psychological risk factors. Prog Cardiovasc Dis (2011) 0.99
Report of a fluoxetine fatality. J Anal Toxicol (1991) 0.99
The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA (1993) 0.99
Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother (1997) 0.99
Sex, ethnicity, and antipsychotic medication use in patients with psychosis. Schizophr Res (2004) 0.98
Cardiovascular effects of tricyclic antidepressants. Annu Rev Med (1984) 0.98
Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry (1987) 0.98
Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther (1999) 0.97
Imipramine-induced heart block. A longitudinal case study. JAMA (1975) 0.96
Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther Drug Monit (2001) 0.96
Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinet (1998) 0.96
Are gender differences important for the clinical effects of antidepressants? Am J Psychiatry (2003) 0.95
To screen or not to screen? Depression in patients with cardiovascular disease. J Am Coll Cardiol (2009) 0.95
Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol (2009) 0.94
Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem (1999) 0.94
Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neurosci (2003) 0.93
Mysterious MAOI hypertensive episodes. J Clin Psychiatry (1986) 0.92
The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation (1979) 0.91
Sex differences in the subjective tolerability of antipsychotic drugs. J Clin Psychopharmacol (2005) 0.89
Concomitant use of antipsychotics and drugs that may prolong the QT interval. J Clin Psychopharmacol (2003) 0.89
Impact of exercise training and depression on survival in heart failure due to coronary heart disease. Am J Cardiol (2011) 0.88
Gender differences in depression and antidepressant pharmacokinetics and adverse events. Ann Pharmacother (2000) 0.88
The effects of hormones on arrhythmias in women. Curr Womens Health Rep (2002) 0.87
Hostility, social support, and carotid artery atherosclerosis in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Cardiol (2000) 0.87
Sex-specific differences in side effects of psychotropic drugs: genes or gender? Pharmacogenomics (2009) 0.87
Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin Ther (2002) 0.86
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet (2012) 4.02
Randomized evidence for reduction of perioperative mortality. J Cardiothorac Vasc Anesth (2012) 3.07
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol (2007) 3.05
Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol (2012) 2.97
Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation. JACC Cardiovasc Interv (2008) 2.90
Targeting interleukin-1 in heart disease. Circulation (2013) 2.52
Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med (2012) 2.47
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol (2005) 2.42
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J (2005) 2.33
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ (2013) 2.26
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes. Int J Cardiol (2010) 2.23
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J (2006) 2.22
Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am J Cardiol (2009) 2.21
Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med (2010) 2.20
Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Imaging (2012) 2.19
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. Am Heart J (2013) 2.09
Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv (2012) 2.05
Novel approaches for preventing or limiting events in diabetic patients (Naples-diabetes) trial: a randomized comparison of 3 drug-eluting stents in diabetic patients. Circ Cardiovasc Interv (2011) 1.86
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol (2008) 1.86
Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention (2012) 1.85
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A (2011) 1.81
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc (2013) 1.77
Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth (2009) 1.77
Cirrhotic cardiomyopathy. J Am Coll Cardiol (2010) 1.77
Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J (2005) 1.74
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol (2008) 1.73
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysis. J Psychopharmacol (2009) 1.70
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials. Ann Emerg Med (2008) 1.64
Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol (2002) 1.63
Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. Atherosclerosis (2012) 1.63
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. Am Heart J (2011) 1.59
Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. Am Heart J (2008) 1.58
Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J (2008) 1.58
Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth (2009) 1.57
Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth (2008) 1.56
Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial. Circ Cardiovasc Interv (2012) 1.54
Use of a second buddy wire during percutaneous coronary interventions: a simple solution for some challenging situations. J Invasive Cardiol (2005) 1.52
Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis. Int J Cardiol (2005) 1.50
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial. Int J Cardiol (2013) 1.50
Operator radiation exposure during percutaneous coronary procedures through the left or right radial approach: the TALENT dosimetric substudy. Circ Cardiovasc Interv (2011) 1.49
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. Int J Cardiol (2006) 1.48
Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol (2007) 1.46
Reduction of scatter radiation during transradial percutaneous coronary angiography: a randomized trial using a lead-free radiation shield. Catheter Cardiovasc Interv (2011) 1.46
A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy. J Nucl Cardiol (2014) 1.45
Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling. Catheter Cardiovasc Interv (2008) 1.44
Swan-Ganz-induced pulmonary artery rupture: management with stent graft implantation. Catheter Cardiovasc Interv (2010) 1.44
Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes: immediate and 2-year outcomes. Catheter Cardiovasc Interv (2011) 1.44
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI. J Invasive Cardiol (2008) 1.44
A tailored approach to overcoming challenges of a bovine aortic arch during left internal carotid artery stenting. J Endovasc Ther (2012) 1.42
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry. J Invasive Cardiol (2011) 1.42
Early and long-term results of percutaneous coronary intervention for unprotected left main trifurcation disease. Catheter Cardiovasc Interv (2009) 1.42
Provisional T-drug-eluting stenting technique for the treatment of bifurcation lesions: clinical, myocardial scintigraphy and (late) coronary angiographic results. J Invasive Cardiol (2007) 1.41
A comprehensive appraisal of meta-analyses focusing on nonsurgical treatments aimed at decreasing perioperative mortality or major cardiac complications. J Anesth (2012) 1.41
Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention (2011) 1.40
Percutaneous removal of an embolized port catheter: description of a new coaxial recovery technique including a case-report. Catheter Cardiovasc Interv (2008) 1.40
Long-term outcomes of elective drug-eluting stenting of the unprotected left main coronary artery in patients with normal left ventricular function. Catheter Cardiovasc Interv (2011) 1.40
Feasibility of sequential thrombus aspiration and filter distal protection in the management of very high thrombus burden lesions. J Invasive Cardiol (2007) 1.40
Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide. Circulation (2009) 1.40
Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J (2012) 1.39
Left ventricular assist devices in chronic heart failure: more questions than answers? J Am Coll Cardiol (2013) 1.39
Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions. Catheter Cardiovasc Interv (2009) 1.39
The PREHAMI (PREsillion™ in high-risk acute myocardial infarction) registry: in-hospital and long-term outcomes. Catheter Cardiovasc Interv (2011) 1.39
Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function. Catheter Cardiovasc Interv (2010) 1.39
Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv (2010) 1.38
Transradial approach (left vs right) and procedural times during percutaneous coronary procedures: TALENT study. Am Heart J (2011) 1.31
Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol (2013) 1.31
Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol (2013) 1.26
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials (2012) 1.26
Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J (2011) 1.26
Are propensity scores really superior to standard multivariable analysis? Contemp Clin Trials (2011) 1.25
Sex-related differences in myocardial remodeling. J Am Coll Cardiol (2010) 1.25
Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J Mol Cell Cardiol (2011) 1.23
Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail (2012) 1.23
A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol (2005) 1.22
Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg (2004) 1.22
Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience. Catheter Cardiovasc Interv (2007) 1.20
Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol (2003) 1.20
Electron microscopy characterization of cardiomyocyte apoptosis in ischemic heart disease. Int J Cardiol (2005) 1.19
Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med (2011) 1.19
A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol (2012) 1.18
ST segment elevation and new right bundle branch block: broadening the differential diagnosis. Int J Cardiol (2006) 1.17
Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.17
Volatile anesthetics reduce mortality in cardiac surgery. J Cardiothorac Vasc Anesth (2009) 1.16
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V). Vasc Health Risk Manag (2008) 1.12